Annual EPS
-$3.28
+$2.02+38.11%
December 31, 2023
Summary
- As of February 26, 2025, RLMD annual earnings per share is -$3.28, with the most recent change of +$2.02 (+38.11%) on December 31, 2023.
- During the last 3 years, RLMD annual EPS has risen by +$0.53 (+13.91%).
- RLMD annual EPS is now -38488.24% below its all-time high of -$0.01, reached on August 31, 2012.
Performance
RLMD EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.72
-$0.13-22.03%
September 30, 2024
Summary
- As of February 26, 2025, RLMD quarterly earnings per share is -$0.72, with the most recent change of -$0.13 (-22.03%) on September 30, 2024.
- Over the past year, RLMD quarterly EPS has stayed the same.
- RLMD quarterly EPS is now -126.09% below its all-time high of $2.76, reached on June 30, 2015.
Performance
RLMD Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$2.86
+$0.01+0.35%
September 30, 2024
Summary
- As of February 26, 2025, RLMD TTM earnings per share is -$2.86, with the most recent change of +$0.01 (+0.35%) on September 30, 2024.
- Over the past year, RLMD TTM EPS has increased by +$0.26 (+8.33%).
- RLMD TTM EPS is now -158.61% below its all-time high of $4.88, reached on September 30, 2015.
Performance
RLMD TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
RLMD EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.1% | 0.0% | +8.3% |
| 3 y3 years | +13.9% | +70.5% | +56.9% |
| 5 y5 years | -19.7% | -89.5% | -25.4% |
RLMD EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.2% | -22.0% | +60.0% | at high | +60.3% |
| 5 y | 5-year | -326.0% | +54.2% | -89.5% | +70.5% | -88.2% | +60.3% |
| alltime | all time | <-9999.0% | +90.5% | -126.1% | +95.1% | -158.6% | +80.5% |
Relmada Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.72(+22.0%) | -$2.86(-0.3%) |
| Jun 2024 | - | -$0.59(-18.1%) | -$2.87(-8.0%) |
| Mar 2024 | - | -$0.72(-13.3%) | -$3.12(-4.6%) |
| Dec 2023 | -$3.28(-38.1%) | -$0.83(+13.7%) | -$3.27(-11.6%) |
| Sep 2023 | - | -$0.73(-13.1%) | -$3.70(-13.6%) |
| Jun 2023 | - | -$0.84(-3.4%) | -$4.28(-10.3%) |
| Mar 2023 | - | -$0.87(-31.0%) | -$4.77(-10.0%) |
| Dec 2022 | -$5.30(-26.0%) | -$1.26(-3.8%) | -$5.30(-9.2%) |
| Sep 2022 | - | -$1.31(-1.5%) | -$5.84(-16.2%) |
| Jun 2022 | - | -$1.33(-5.0%) | -$6.97(-3.2%) |
| Mar 2022 | - | -$1.40(-22.2%) | -$7.20(+0.8%) |
| Dec 2021 | -$7.16(+87.9%) | -$1.80(-26.2%) | -$7.14(+7.7%) |
| Sep 2021 | - | -$2.44(+56.4%) | -$6.63(+26.5%) |
| Jun 2021 | - | -$1.56(+16.4%) | -$5.24(+18.8%) |
| Mar 2021 | - | -$1.34(+3.9%) | -$4.41(+16.4%) |
| Dec 2020 | -$3.81(+394.8%) | -$1.29(+22.9%) | -$3.79(+51.6%) |
| Sep 2020 | - | -$1.05(+43.8%) | -$2.50(+36.6%) |
| Jun 2020 | - | -$0.73(+1.4%) | -$1.83(+20.4%) |
| Mar 2020 | - | -$0.72(+89.5%) | -$1.52(-33.3%) |
| Dec 2019 | -$0.77(-71.9%) | - | - |
| Sep 2019 | - | -$0.38(-9.5%) | -$2.28(-23.5%) |
| Jun 2019 | -$2.74(-4.2%) | -$0.42(+16.7%) | -$2.98(-17.7%) |
| Mar 2019 | - | -$0.36(-67.9%) | -$3.62(-15.8%) |
| Dec 2018 | - | -$1.12(+3.7%) | -$4.30(+18.8%) |
| Sep 2018 | - | -$1.08(+1.9%) | -$3.62(+26.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | -$2.86(+37.5%) | -$1.06(+1.9%) | -$2.86(+23.3%) |
| Mar 2018 | - | -$1.04(+136.4%) | -$2.32(+20.8%) |
| Dec 2017 | - | -$0.44(+37.5%) | -$1.92(+4.3%) |
| Sep 2017 | - | -$0.32(-38.5%) | -$1.84(-11.5%) |
| Jun 2017 | -$2.08(+100.0%) | -$0.52(-18.8%) | -$2.08(-23.5%) |
| Mar 2017 | - | -$0.64(+77.8%) | -$2.72(+1.5%) |
| Dec 2016 | - | -$0.36(-35.7%) | -$2.68(-16.3%) |
| Sep 2016 | - | -$0.56(-51.7%) | -$3.20(+166.7%) |
| Jun 2016 | -$1.04(-87.6%) | -$1.16(+93.3%) | -$1.20(-144.1%) |
| Mar 2016 | - | -$0.60(-31.8%) | $2.72(+13.3%) |
| Dec 2015 | - | -$0.88(-161.1%) | $2.40(-50.8%) |
| Sep 2015 | - | $1.44(-47.8%) | $4.88(-143.6%) |
| Jun 2015 | -$8.36(-75.8%) | $2.76(-400.0%) | -$11.20(-19.8%) |
| Mar 2015 | - | -$0.92(-157.5%) | -$13.96(+7.0%) |
| Dec 2014 | - | $1.60(-110.9%) | -$13.04(-11.0%) |
| Sep 2014 | - | -$14.64(>+9900.0%) | -$14.65(>+9900.0%) |
| Jun 2014 | -$34.60(>+9900.0%) | - | - |
| Feb 2014 | - | -$0.00(-78.2%) | -$0.03(-2.0%) |
| Nov 2013 | - | -$0.01(+16.1%) | -$0.04(+12.0%) |
| Aug 2013 | -$0.03(+271.8%) | -$0.01(-36.5%) | -$0.03(+9.0%) |
| May 2013 | - | -$0.01(+372.4%) | -$0.03(+70.6%) |
| Feb 2013 | - | -$0.00(-54.0%) | -$0.02(+17.2%) |
| Nov 2012 | - | -$0.01(+3.3%) | -$0.01(+76.8%) |
| Aug 2012 | -$0.01 | -$0.01(+258.8%) | -$0.01(+290.5%) |
| May 2012 | - | -$0.00(+325.0%) | -$0.00(+425.0%) |
| Feb 2012 | - | -$0.00 | -$0.00 |
FAQ
- What is Relmada Therapeutics annual earnings per share?
- What is the all time high annual EPS for Relmada Therapeutics?
- What is Relmada Therapeutics annual EPS year-on-year change?
- What is Relmada Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly EPS year-on-year change?
- What is Relmada Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Relmada Therapeutics?
- What is Relmada Therapeutics TTM EPS year-on-year change?
What is Relmada Therapeutics annual earnings per share?
The current annual EPS of RLMD is -$3.28
What is the all time high annual EPS for Relmada Therapeutics?
Relmada Therapeutics all-time high annual earnings per share is -$0.01
What is Relmada Therapeutics annual EPS year-on-year change?
Over the past year, RLMD annual earnings per share has changed by +$2.02 (+38.11%)
What is Relmada Therapeutics quarterly earnings per share?
The current quarterly EPS of RLMD is -$0.72
What is the all time high quarterly EPS for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly earnings per share is $2.76
What is Relmada Therapeutics quarterly EPS year-on-year change?
Over the past year, RLMD quarterly earnings per share has changed by $0.00 (0.00%)
What is Relmada Therapeutics TTM earnings per share?
The current TTM EPS of RLMD is -$2.86
What is the all time high TTM EPS for Relmada Therapeutics?
Relmada Therapeutics all-time high TTM earnings per share is $4.88
What is Relmada Therapeutics TTM EPS year-on-year change?
Over the past year, RLMD TTM earnings per share has changed by +$0.26 (+8.33%)